1. Home
  2. SANW vs CODX Comparison

SANW vs CODX Comparison

Compare SANW & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANW
  • CODX
  • Stock Information
  • Founded
  • SANW 1980
  • CODX 2013
  • Country
  • SANW United States
  • CODX United States
  • Employees
  • SANW N/A
  • CODX N/A
  • Industry
  • SANW Farming/Seeds/Milling
  • CODX Medical/Dental Instruments
  • Sector
  • SANW Consumer Staples
  • CODX Health Care
  • Exchange
  • SANW Nasdaq
  • CODX Nasdaq
  • Market Cap
  • SANW 12.0M
  • CODX 9.8M
  • IPO Year
  • SANW 2010
  • CODX 2017
  • Fundamental
  • Price
  • SANW $2.20
  • CODX $0.28
  • Analyst Decision
  • SANW Strong Buy
  • CODX Buy
  • Analyst Count
  • SANW 1
  • CODX 2
  • Target Price
  • SANW $25.00
  • CODX $5.50
  • AVG Volume (30 Days)
  • SANW 73.8K
  • CODX 462.7K
  • Earning Date
  • SANW 05-15-2025
  • CODX 08-07-2025
  • Dividend Yield
  • SANW N/A
  • CODX N/A
  • EPS Growth
  • SANW N/A
  • CODX N/A
  • EPS
  • SANW N/A
  • CODX N/A
  • Revenue
  • SANW $54,993,808.00
  • CODX $3,497,583.00
  • Revenue This Year
  • SANW N/A
  • CODX N/A
  • Revenue Next Year
  • SANW $17.19
  • CODX $42.11
  • P/E Ratio
  • SANW N/A
  • CODX N/A
  • Revenue Growth
  • SANW 6.91
  • CODX N/A
  • 52 Week Low
  • SANW $1.99
  • CODX $0.23
  • 52 Week High
  • SANW $11.60
  • CODX $2.23
  • Technical
  • Relative Strength Index (RSI)
  • SANW 19.42
  • CODX 43.19
  • Support Level
  • SANW $2.00
  • CODX $0.26
  • Resistance Level
  • SANW $5.37
  • CODX $0.29
  • Average True Range (ATR)
  • SANW 0.39
  • CODX 0.02
  • MACD
  • SANW -0.39
  • CODX 0.00
  • Stochastic Oscillator
  • SANW 5.63
  • CODX 26.83

About SANW S&W Seed Company (NV)

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: